节点文献
合并门静脉高压症肝癌患者的外科治疗
Study of Surgical Treatment for Hepatocellular Carcinoma with Portal Hypertension
【摘要】 目的:总结合并门静脉高压症肝癌患者的外科治疗经验。方法:回顾性分析1998年1月至2003年9月外科手术的27例合并门静脉高压症肝癌患者的手术资料、术后近期并发症及随访情况。其中4例术前或术后行脾动脉检塞术、2例行胃冠状静脉缝扎术,另行单纯脾切除术、单纯贲门周围血管断离术及脾切除并贲门周围血管断离术各1例。结果:除1例术后2周因上消化道大出血、肝昏迷死亡(手术死亡率3.7%)外,其余26例皆康复出院。术后近期并发症发生率74.1%,术后3月、6月及1、2、3、5年生存率分别为88.9%、70.3%、55.6%、37.0%、29.6%、0%。结论:合并门静脉高压症肝癌的手术切除有较高的并发症,合理的围手术期处理仍可保证手术的安全及术后顺利恢复。手术切除可以延长合并门静脉高压症肝癌患者的生存期。
【Abstract】 Objective:To study the surgical management for hepatocellular carcinoma with portal hypertension.Methods:From Jan,1998 Ao Sep,2003 there were 27 hepatocellular Carcinoma patients with portal hypertension in our department.They received hepatic lobectomyonly or combined with operation on hepatocellular carcinoma and portal hypertension.Results: Operative mortality and complication rate were3.7% and 74.1% respectively,the postoperative survival rates of 3-、6- month and 1-、2-、3-、5-year were 88.9%,70.3%,55.6%,37.0%,29.6% and 0% respeotinely.Conclusion:Our study suggestes that the surgical treatmnt for hepatocellular Carcinoma with portal hypertensioncan prolong the Survinal time of patients.
【Key words】 Hepatocellular Carcinoma; Portal Hypertension; Surgical Management;
- 【文献出处】 四川肿瘤防治 ,Sichuan Journal of Cancer Control , 编辑部邮箱 ,2004年02期
- 【分类号】R735.7
- 【下载频次】34